Defence Therapeutics Inc. (FRA:DTC)
Germany · Delayed Price · Currency is EUR 0.3800
-0.0400 (-9.52%)
At close: Jan 30, 2026
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of €19.58 million as of January 30, 2026. Its market cap has decreased by -4.88% in one year.
Market Cap
19.58M
Enterprise Value
19.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.38
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 60.36M to 19.58M, a decrease of -67.56%. That is a compound annual growth rate of -21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 19.58M | -23.69% |
| Dec 31, 2025 | 25.66M | 21.41% |
| Dec 31, 2024 | 21.13M | -70.23% |
| Dec 29, 2023 | 70.98M | 4.33% |
| Dec 30, 2022 | 68.04M | -49.69% |
| Dec 31, 2021 | 135.24M | 124.04% |
| May 7, 2021 | 60.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 28.58M |
| Rubean AG | 27.29M |
| Hyrican Informationssysteme Aktiengesellschaft | 22.80M |
| Petro Matad | 22.31M |
| ACCENTRO Real Estate AG | 21.00M |
| Pearl Gold AG | 18.75M |
| 123fahrschule SE | 16.79M |